These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3726933)

  • 21. NONMEM analysis in determining the tri-exponential disposition of cefotaxime: a method of evaluating serum and urinary phase I data.
    Weber W; Harnisch L; Zimmer M; Rokitta C; Mendes P
    Int J Clin Pharmacol Ther; 1995 Oct; 33(10):560-4. PubMed ID: 8574507
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of cefotaxime in neonatal pony foals.
    Gardner SY; Sweeney RW; Divers TJ
    Am J Vet Res; 1993 Apr; 54(4):576-9. PubMed ID: 8484578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of cefotaxime and desacetylcefotaxime in elderly patients.
    Ludwig E; Székely E; Csiba A; Graber H
    Drugs; 1988; 35 Suppl 2():51-6. PubMed ID: 3396489
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative pharmacokinetics of cefotaxime and ceftizoxime and the role of desacetylcefotaxime in the antibacterial activity of cefotaxime.
    Quintiliani R; Nightingale CH; Tilton R
    Diagn Microbiol Infect Dis; 1984 Jun; 2(3 Suppl):63S-70S. PubMed ID: 6086220
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Concentrations of cefotaxime and the desacetyl metabolite in serum and CSF of patients with meningitis.
    Humbert G; Leroy A; Nair SR; Cherubin CE
    J Antimicrob Chemother; 1984 May; 13(5):487-94. PubMed ID: 6330021
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Studies on the pharmacokinetics of cefotaxime in neonates].
    Nishimura T; Takashima T; Hiromatsu K; Tabuki K
    Jpn J Antibiot; 1982 Jul; 35(7):1793-800. PubMed ID: 6294360
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cefotaxime, desacetyl-cefotaxime, and bactericidal activity in spontaneous bacterial peritonitis.
    Dalmau D; Layrargues GP; Fenyves D; Willems B; Turgeon F; Turgeon P
    J Infect Dis; 1999 Nov; 180(5):1597-602. PubMed ID: 10515821
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The cooperation of cefotaxime and desacetyl-cefotaxime with respect to antibacterial activity and beta-lactamase stability.
    Limbert M; Seibert G; Schrinner E
    Infection; 1982; 10(2):97-100. PubMed ID: 6284653
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of ceftriaxone following intravenous administration of a 3 g dose.
    McNamara PJ; Stoeckel K; Ziegler WH
    Eur J Clin Pharmacol; 1982; 22(1):71-5. PubMed ID: 6284519
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Elimination of desacetyl cefotaxime in geriatric patients with multiple diseases].
    Mühlberg W; Platt D
    Klin Wochenschr; 1982 Dec; 60(24):1497-500. PubMed ID: 6300510
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pharmacokinetics of cefotaxime and desacetylcefotaxime in the blood serum and bronchial secretion in patients with chronic bronchitis after administration of a single 24-hour dose].
    Kamnev IuV; Manuĭlov KK; Orlov VA; Sokolova VI
    Antibiot Khimioter; 1991 Oct; 36(10):42-4. PubMed ID: 1805696
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of cefotaxime in the domestic cat.
    McElroy D; Ravis WR; Clark CH
    Am J Vet Res; 1986 Jan; 47(1):86-8. PubMed ID: 3946912
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma and peritoneal concentration following continuous infusion of cefotaxime in patients with secondary peritonitis.
    Seguin P; Verdier MC; Chanavaz C; Engrand C; Laviolle B; Donnio PY; Mallédant Y
    J Antimicrob Chemother; 2009 Mar; 63(3):564-7. PubMed ID: 19168542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rapid chromatographic determination of cefotaxime and its metabolite in biological fluids.
    Yost RL; Derendorf H
    J Chromatogr; 1985 May; 341(1):131-8. PubMed ID: 3894403
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of cefotaxime in the dog.
    Guerrini VH; English PB; Filippich LJ; Schneider J; Bourne DW
    Vet Rec; 1986 Jul; 119(4):81-3. PubMed ID: 3750783
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pharmacokinetic behavior of cefsulodin and cefotiam alone or in combination after intravenous injection of 1 gram].
    Fourtillan JB; Bryskier A; Lefebvre MA; Ingrand I
    Pathol Biol (Paris); 1984 Jun; 32(5 Pt 2):501-5. PubMed ID: 6087247
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cefotaxime concentration in the prostatic tissue].
    Fujita K; Fujita HM; Fujii K; Masuda H; Ushiyama T; Tajima A; Aso Y
    Jpn J Antibiot; 1983 Jun; 36(6):1465-8. PubMed ID: 6197541
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Absolute bioavailability of ceftriaxone after intramuscular administration to healthy volunteers.
    Delsignore R; Baroni CM; Crotti G; Mineo F; Butturini U; Ascalone V; Cisternino M
    Chemotherapy; 1983; 29(3):157-62. PubMed ID: 6307601
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolism of cefotaxime: a review.
    Lassman HB; Coombes JD
    Diagn Microbiol Infect Dis; 1984 Jun; 2(3 Suppl):3S-12S. PubMed ID: 6086216
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Single-dose ceftriaxone kinetics in liver insufficiency.
    Stoeckel K; Tuerk H; Trueb V; McNamara PJ
    Clin Pharmacol Ther; 1984 Oct; 36(4):500-9. PubMed ID: 6090050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.